Regulator seeks views on innovative medicines manufacture at point of care
We are seeking the views of industry, the medical community, patients and the public. The consultation will run for six weeks.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 12 August 2021 here
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (9 mars 2022). Regulator seeks views on innovative medicines manufacture at point of care. ELSIBI. Consulté le 11 janvier 2026 à l’adresse https://doi.org/10.58079/o5tz





